Yahoo Web Search

Search results

1. • TCG Advisory Services LLC Increases Stock Holdings in Johnson & Johnson (NYSE:JNJ)

     ETF DAILY NEWS· 6 days ago

     TCG Advisory Services LLC boosted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 32.1% during the 4th quarter, according to its most recent 13F filing with the Securities and ...

2. • What Is the Dividend Payout for AbbVie Stock?

     The Motley Fool via AOL· 2 days ago

     AbbVie's plan for life after Humira AbbVie is the company behind cancer-fighting Imbruvica as well as arthritis/Crohn's disease treatment Skyrizi. Its claim-to-fame drug, however, is

3. • Are you searching for a natural solution to arthritis pain? - Times Leader

     Times Leader· 3 days ago

     People who suffer from arthritis pain frequently resort to costly surgery, steroid injections, and prescription medications to alleviate their symptoms. Arthritis does not discriminate, and ...

4. • People in the News at Scipher Medicine, NanoString Technologies, Jackson Lab

     GenomeWeb News· 5 days ago

     Scipher Medicine, which markets the PrismRA blood test to guide precision rheumatoid arthritis therapy, has appointed Reginald Seeto as CEO and president ...

5. • 

     A Baffling Rise In MS Cases Has Doctors Seeking Answers To The ‘Billion Dollar Question’

     Women's Health via Yahoo News· 6 days ago

     Multiple Sclerosis diagnoses have been rising globally since 2013, and in 2019, an estimated 1...

6. • 

     Pima County parents indicted on first-degree murder charges in death of son with disabilities

     The Arizona Republic· 4 days ago

     Upon arriving, the deputies noticed that the child’s death had taken place under “suspicious...

7. • Breed s Hill Capital LLC Makes New $482,000 Investment in Johnson & Johnson (NYSE:JNJ)

     ETF DAILY NEWS· 3 days ago

     Breed s Hill Capital LLC acquired a new stake in Johnson & Johnson (NYSE:JNJ – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange ...

8. • AbbVie widens search for next hit drug with psychiatric deal worth up to $2B

     Crain s Chicago Business· 2 days ago

     AbbVie, which already has a growing psychiatry portfolio, is paying Gilgamesh $65 million upfront and as much as $1.95 billion in aggregate option fees and milestones in the future. Under the ...

9. • Scipher Medicine: Reginald Seeto, Glen Muir | GenomeWeb

     GenomeWeb News· 6 days ago

     Scipher Medicine, which markets the PrismRA blood test to guide precision rheumatoid arthritis therapy, has appointed Reginald Seeto as CEO and president ...

10. • 

      FEMA is still spending millions on hundreds of empty housing units for Maui fire survivors

      The Raw Story· 6 days ago

      This story was originally published by Honolulu Civil Beat. You can sign up for Civil Beat's...